Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation

Infections and graft‐versus‐host disease (GVHD) are the main causes of transplant‐related mortality (TRM) of patients undergoing allo‐SCT. The role of iron overload (IO) has been debated in this context. Studies, performed with non‐specific surrogate markers of iron, suggest that IO predicts poor outcome after allo‐SCT.

[1]  M. Laniado,et al.  MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation , 2012, Clinical Cancer Research.

[2]  G. Divine,et al.  Iron overload in allogeneic hematopoietic stem cell transplant recipients. , 2012, Archives of pathology & laboratory medicine.

[3]  D. Swinkels,et al.  Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. , 2012, The Journal of clinical investigation.

[4]  R. Parkkola,et al.  The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease , 2012, Blood Cancer Journal.

[5]  R. Kwong,et al.  Does iron overload really matter in stem cell transplantation? , 2011, American journal of hematology.

[6]  H. Paşaoğlu,et al.  Pro‐oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation , 2011, International journal of laboratory hematology.

[7]  M. Fleming,et al.  Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  A. Wåhlin,et al.  Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts , 2011, Medical oncology.

[9]  M. Cazzola,et al.  The relevance of transfusion‐dependency in the prognostic assessment of patients with myeloid neoplasms , 2011, American journal of hematology.

[10]  Y. Ishigatsubo,et al.  Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies , 2011, International journal of hematology.

[11]  G. Weiss,et al.  The struggle for iron – a metal at the host–pathogen interface , 2010, Cellular microbiology.

[12]  M. Aydoğdu,et al.  Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload , 2010, Bone Marrow Transplantation.

[13]  Ş. Akı,et al.  Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation. , 2010, Transplantation proceedings.

[14]  C. Pascutto,et al.  Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study , 2010, Haematologica.

[15]  J. Antin,et al.  Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation , 2010, Haematologica.

[16]  L. Rybicki,et al.  Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation , 2009, Bone Marrow Transplantation.

[17]  R. Brand,et al.  Risk score for outcome after allogeneic hematopoietic stem cell transplantation , 2009, Cancer.

[18]  L. Rybicki,et al.  Elevated pretransplant ferritin is associated with a lower incidence of chronic graft‐versus‐host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation , 2009, British journal of haematology.

[19]  Lijian Wang,et al.  Ironing Out the Wrinkles in Host Defense: Interactions between Iron Homeostasis and Innate Immunity , 2009, Journal of Innate Immunity.

[20]  T. Ganz.  Iron in innate immunity: starve the invaders. , 2009, Current opinion in immunology.

[21]  M. Kurokawa,et al.  Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  J. Wood.  Cardiac iron across different transfusion-dependent diseases. , 2008, Blood reviews.

[23]  J. Ito,et al.  Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation , 2008, Bone Marrow Transplantation.

[24]  H. Deeg,et al.  Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  R. Parkkola,et al.  Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. , 2008, Magnetic resonance imaging.

[26]  H. Lazarus,et al.  Iron overload in hematopoietic cell transplantation , 2008, Bone Marrow Transplantation.

[27]  Russell E. Lewis,et al.  Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high‐risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation , 2007, Cancer.

[28]  I. Yakoub-Agha,et al.  Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT). , 2007, Haematologica.

[29]  T. Coates,et al.  MRI detects myocardial iron in the human heart , 2006, Magnetic resonance in medicine.

[30]  B. Barlogie,et al.  Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients , 2006, Bone Marrow Transplantation.

[31]  R. Kamble,et al.  Iron-overload in long-term survivors of hematopoietic transplantation , 2006, Bone Marrow Transplantation.

[32]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[33]  T. S. St. Pierre,et al.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.

[34]  L. Gordon,et al.  Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress , 2004, Bone Marrow Transplantation.

[35]  J. Briones,et al.  Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis , 2004, Bone Marrow Transplantation.

[36]  D. Pennell,et al.  A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload , 2003, Journal of magnetic resonance imaging : JMRI.

[37]  A. Brand.  Immunological aspects of blood transfusions. , 2002, Transplant immunology.

[38]  J. Briones,et al.  Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[39]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[40]  H. Lazarus,et al.  Chronic graft-versus-host disease: clinical manifestation and therapy , 2001, Bone Marrow Transplantation.

[41]  T. Ruutu,et al.  Non‐transferrin‐bound iron during allogeneic stem cell transplantation , 2001, British journal of haematology.

[42]  M. Kami,et al.  Hepatic iron concentration and total body iron stores in thalassemia major. , 2000, The New England journal of medicine.

[43]  R. Fischer,et al.  Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. , 2000, The Journal of laboratory and clinical medicine.

[44]  G. Brittenham,et al.  Iron-chelating therapy and the treatment of thalassemia. , 1997, Blood.

[45]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[46]  H. Leitch.  Controversies surrounding iron chelation therapy for MDS. , 2011, Blood reviews.

[47]  A. Barrett.  CHAPTER 2 – Essential biology of stem cell transplantation , 2009 .

[48]  J. D. Johnston.  Non-invasive assessment of hepatic iron stores by MRI. , 2004, Annals of clinical biochemistry.

[49]  G. Brittenham,et al.  Noninvasive measurement of iron: report of an NIDDK workshop. , 2003, Blood.